← Eichor
Study identifier: NCT04986891 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we Care

Condition: CIPN  ·  Sponsor: University of Milano Bicocca

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a pilot, observational, cross-sectional, study on socio-economic burden related to chemotherapy-induced peripheral neurotoxicity (CIPN). Investigators will collect CIPN healthcare related costs on a detailed clinical patient-level. As a sub-study, data obtained in this cross-sectional study, will be compared with administrative larger datasets on patients affected by cancer. The aim is to run a test for potential proxy variables which are available in larger administrative datasets, even if not directly measuring CIPN, to learn more about the impact of CIPN.

This description comes directly from the study's public registry record.

Talk to the study team

Paola Alberti, MD  ·  +39 02 6448 8154  ·  paola.alberti@unimib.it

Always discuss trial participation with your own doctor first.

Locations (1)

ASST MonzaMonza, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04986891